Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:191-200
Published online before print June 15, 2006, doi: 10.1161/01.RES.0000232319.02303.8c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
99/2/191    most recent
01.RES.0000232319.02303.8cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sukhanov, S.
Right arrow Articles by Delafontaine, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sukhanov, S.
Right arrow Articles by Delafontaine, P.
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2006;99:191.)
© 2006 American Heart Association, Inc.


Cellular Biology

Novel Effect of Oxidized Low-Density Lipoprotein

Cellular ATP Depletion via Downregulation of Glyceraldehyde-3-Phosphate Dehydrogenase

Sergiy Sukhanov, Yusuke Higashi, Shaw-Yung Shai, Hiroyuki Itabe, Koichi Ono, Sampath Parthasarathy, Patrick Delafontaine

From the Cardiology Section (S.S., Y.H., S.-Y.S, P.D.), Department of Medicine, Tulane University, New Orleans, La; Department of Biological Chemistry (H.I.), Showa University, Tokyo, Japan; Innoshima City Medical Associated Hospital (K.O.), Japan; and Pathology Department (S.P.), Louisiana State University, New Orleans.

Correspondence to Patrick Delafontaine, Cardiology Section, Department of Medicine, TUHSC, 1430 Tulane Ave, SL-48, New Orleans, LA 70112-2699. E-mail pdelafon{at}tulane.edu

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a classical glycolytic enzyme that is involved in cellular energy production and has important housekeeping functions. We used the natural prooxidant and proatherogenic molecule oxidized low-density lipoprotein (OxLDL) to determine a potential link between OxLDL-promoted oxidative stress, GAPDH expression, and smooth muscle cell energy metabolism. OxLDL but not native LDL (nLDL) produced a 60% to 100% dose- and time-dependent reduction of GAPDH protein. OxLDL increased reactive oxygen species (ROS) formation, including rapid elevation of H2O2 levels. OxLDL decreased intracellular catalase expression, likely contributing to the increase in H2O2. Antioxidants, anti-CD36 receptor antibody, NADPH oxidase, or lipoxygenase blockers decreased OxLDL-specific ROS and prevented GAPDH downregulation. 12/15-Lipoxygenase or p47phox deficiency resulted in attenuation of GAPDH downregulation, but 5-lipoxygenase suppression had no effect. OxLDL or exogenous H2O2 oxidized GAPDH thiols, decreasing GAPDH protein half-life and increasing GAPDH sensitivity to proteasome-mediated protein degradation in vitro. OxLDL- or small interfering RNA–specific downregulation of GAPDH resulted in 65% reduction in glycolysis rate and 82% decrease in ATP levels. In conclusion, our data demonstrate that OxLDL downregulated GAPDH via a H2O2-dependent decrease in protein stability. GAPDH protein damage resulted in marked depletion of cellular ATP levels. Our data have important implications for understanding the metabolic effect of OxLDL on the vessel wall and mechanism of atherogenesis.


Key Words: reactive oxygen species • low-density lipoprotein • energy metabolism • vascular smooth muscle




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Sukhanov, Y. Higashi, S.-Y. Shai, C. Vaughn, J. Mohler, Y. Li, Y.-H. Song, J. Titterington, and P. Delafontaine
IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atherosclerosis Progression in ApoE-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2684 - 2690.
[Abstract] [Full Text] [PDF]